Physician profile
Joshua David Smith
NPI 1841588415
$3,270.07
in general payments reported to CMS, 2019-2025
12 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,378 · 2020: $28.42 · 2022: $247 · 2023: $20.61 · 2024: $227 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.64 |
| Travel and Lodging | $160.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,180.50 | 2019 | |
| Encore Medical, LP | $1,178.91 | 2019 | |
| Boston Scientific Corporation | $276.19 | 2022-2025 | Ams 700, Wavewriter Alpha Prime 16 |
| Stryker Corporation | $253.88 | 2025 | Core, Scopis Ent |
| Integra Lifesciences Corporation | $90.91 | 2022 | |
| Medtronic, INC. | $82.85 | 2024 | |
| Piedmont Plus Innovation | $76.17 | 2022 | |
| Zimmer Biomet Holdings, INC. | $37.09 | 2019-2022 | |
| Depuy Synthes Sales INC. | $28.66 | 2025 | Na |
| Smith+Nephew, INC. | $28.42 | 2020 | |
| Shoulder Innovations, INC. | $25.50 | 2025 | Inset System |
| Checkpoint Surgical, INC | $10.99 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.